These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 36029975)

  • 1. Utility of NO and H
    Oza PP; Kashfi K
    Nitric Oxide; 2022 Nov; 128():72-102. PubMed ID: 36029975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased availability of nitric oxide and hydrogen sulfide is a hallmark of COVID-19.
    Dominic P; Ahmad J; Bhandari R; Pardue S; Solorzano J; Jaisingh K; Watts M; Bailey SR; Orr AW; Kevil CG; Kolluru GK
    Redox Biol; 2021 Jul; 43():101982. PubMed ID: 34020311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrogen Sulfide: Physiological Roles and Therapeutic Implications against COVID-19.
    Abolfazli S; Ebrahimi N; Morabi E; Asgari Yazdi MA; Zengin G; Sathyapalan T; Jamialahmadi T; Sahebkar A
    Curr Med Chem; 2024; 31(21):3132-3148. PubMed ID: 37138436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H
    Yang G
    Am J Physiol Cell Physiol; 2020 Aug; 319(2):C244-C249. PubMed ID: 32515982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrogen sulfide: From a toxic gas to a potential therapy for COVID-19 and inflammatory disorders.
    Kumar M
    Nitric Oxide; 2023 Nov; 140-141():8-15. PubMed ID: 37648016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Acetylcysteine and Hydrogen Sulfide in Coronavirus Disease 2019.
    Bourgonje AR; Offringa AK; van Eijk LE; Abdulle AE; Hillebrands JL; van der Voort PHJ; van Goor H; van Hezik EJ
    Antioxid Redox Signal; 2021 Nov; 35(14):1207-1225. PubMed ID: 33607929
    [No Abstract]   [Full Text] [Related]  

  • 7. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
    Quirch M; Lee J; Rehman S
    J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
    Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
    Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harnessing nitric oxide for preventing, limiting and treating the severe pulmonary consequences of COVID-19.
    Adusumilli NC; Zhang D; Friedman JM; Friedman AJ
    Nitric Oxide; 2020 Oct; 103():4-8. PubMed ID: 32681986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Potential Role of Nitric Oxide as a Therapeutic Agent against SARS-CoV-2 Infection.
    Xiao S; Yuan Z; Huang Y
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38138990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents.
    Khadke S; Ahmed N; Ahmed N; Ratts R; Raju S; Gallogly M; de Lima M; Sohail MR
    Virol J; 2020 Oct; 17(1):154. PubMed ID: 33059711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-Wide Characterization of SARS-CoV-2 Cytopathogenic Proteins in the Search of Antiviral Targets.
    Zhang J; Li Q; Cruz Cosme RS; Gerzanich V; Tang Q; Simard JM; Zhao RY
    mBio; 2021 Feb; 13(1):e0016922. PubMed ID: 35164548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric Oxide to Fight Viral Infections.
    Lisi F; Zelikin AN; Chandrawati R
    Adv Sci (Weinh); 2021 Apr; 8(7):2003895. PubMed ID: 33850691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gaseous mediators in resolution of inflammation.
    Wallace JL; Ianaro A; Flannigan KL; Cirino G
    Semin Immunol; 2015 May; 27(3):227-33. PubMed ID: 26095908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide as a double-edged sword in pulmonary viral infections: Mechanistic insights and potential therapeutic implications.
    Masood M; Singh P; Hariss D; Khan F; Yameen D; Siraj S; Islam A; Dohare R; Mahfuzul Haque M
    Gene; 2024 Mar; 899():148148. PubMed ID: 38191100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saying no to SARS-CoV-2: the potential of nitric oxide in the treatment of COVID-19 pneumonia.
    Zhang H; Zhang C; Hua W; Chen J
    Med Gas Res; 2024; 14(2):39-47. PubMed ID: 37929506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune-Modulating Drug MP1032 with SARS-CoV-2 Antiviral Activity In Vitro: A potential Multi-Target Approach for Prevention and Early Intervention Treatment of COVID-19.
    Schumann S; Kaiser A; Nicoletti F; Mangano K; Fagone P; van Wijk E; Yan Y; Schulz P; Ludescher B; Niedermaier M; von Wegerer J; Rauch P; Setz C; Schubert U; Brysch W
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogen Sulfide Is an Antiviral and Antiinflammatory Endogenous Gasotransmitter in the Airways. Role in Respiratory Syncytial Virus Infection.
    Ivanciuc T; Sbrana E; Ansar M; Bazhanov N; Szabo C; Casola A; Garofalo RP
    Am J Respir Cell Mol Biol; 2016 Nov; 55(5):684-696. PubMed ID: 27314446
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.